H.C. Wainwright raised the firm’s price target on Balchem to $185 from $170 and keeps a Buy rating on the shares. The company showed continued solid execution in Q2, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCPC: